NLGN3 is cleaved by ADAM10 (A Disintegrin and Metalloproteinase 10) and is secreted from neurons, inducing phosphorylation and activation of several key receptor tyrosine kinases (RTKs) and downstream signaling cascades in glioma cells [18–21]. Here, NLGN3 is linked to central nervous system cancer.